Transaction:
- SRV Hospitals, a Mumbai-based multi-specialty hospital chain, has raised INR 140 crores in funding from InvAscent, a leading private equity fund focused on the life sciences sector.
- The funding will support SRV’s growth strategy, centered on its multispecialty, critical care-driven healthcare delivery model.
About SRV Hospitals:
- Founded in 2015, SRV Hospitals operates a network of five tertiary care hospitals across Mumbai, Nashik, and Bengaluru, with a combined bed capacity of 500+ beds.
- The group is known for its consultant-led care, robust critical care protocols, high clinical outcomes, and a strong focus on delivering exceptional patient experiences.
About InvAscent:
- InvAscent is a Hyderabad based healthcare-focused private equity firm with over $800 million in assets under management (AUM), actively investing in India’s healthcare ecosystem.
- The firm primarily invests in pharmaceuticals, healthcare services, MedTech, animal health, and has backed over 35 healthcare companies to date, including HCG Hospitals and Dr. Agarwal’s Eye Hospital.
Rationale:
- The fresh capital will be used to expand SRV’s multispecialty, critical care-focused hospital network across existing and new geographies.
- SRV’s investment in advanced medical technologies and infrastructure aims to enhance clinical outcomes, operational efficiency, and support its mission to redefine access to quality tertiary care at the neighborhood level.
- The funding will bolster SRV’s consultant-led care model, improve clinician support systems, and provide both financial and sectoral expertise to advance its operational and strategic goals.
- Funds will be allocated towards both organic and inorganic expansion, helping SRV scale up rapidly.
- This marks InvAscent’s fifth investment from its fourth fund, following its most recent deal in January when it acquired a minority stake in geriatric care service provider, Geri care for Rs. 110 Crore
- InvAscent’s decision to back SRV also follows the PE fund’s successful investments in healthcare brands like HCG Hospitals and Dr Agarwal’s Eye Hospital.
Acknowledgements:
RBI Bulletin (www.bulletin.rbi.org.in), SEBI (www.sebi.gov.in), NSE (www.nseindia.com), BSE (www.bseindia.com)
Disclaimer:
This material has been prepared by the personnel in Vora Corporate Finance which is Investment Banking arm of Vora Management Consultancy Private Limited and looks after Mergers & Acquisitions (M&A), Private Equity (PE), Fund Raising, Debt syndication and Valuations and is based out of Ahmedabad, Gujarat, India. Any views or opinions expressed herein are solely that of individual authors and may differ from view of Vora Management Consultancy Private Limited. This material is proprietary to Vora Management Consultancy Private Limited and is for your personal use only. Any distribution, copy, reprints or forward to others is strictly prohibited.
This material captures the information based on information available in the public domain, public announcements and sources believed to be reliable. Analysis contained herein is based on publicly available information and appropriate assumptions. This material is intended merely to highlight market developments and is not intended to be comprehensive and does not constitute strategic, investment, legal or tax advice. In no event Vora Management Consultancy Private Limited be liable for any use by any party or for any decision made or action taken by any party in reliance upon, or for any inaccuracies or errors in, or omissions from, the information contained herein and such information may not be relied upon by you for evaluating any transaction.